(2) chronic stable angina

Pharmaceutical Journal

Volumn 269, Issue 7215, 2002, Pages 363-365

  Williams, Helen ^a   Stevens, Mel ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIANGINA PECTORIS AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CELIPROLOL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; ISOSORBIDE 5 NITRATE; NICORANDIL; NIFEDIPINE; NITRATE; OXPRENOLOL; OXYGEN; PARACETAMOL; PLACEBO; POTASSIUM CHANNEL STIMULATING AGENT; VERAPAMIL;

ANAMNESIS; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RISK; CONSTIPATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY STENT; DIET THERAPY; DRUG MECHANISM; DYSPNEA; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FATIGUE; HEADACHE; HEART INFARCTION; HUMAN; HYPOTENSION; ISCHEMIC HEART DISEASE; LETHARGY; LIFESTYLE; MEDICAL DECISION MAKING; OXYGEN TRANSPORT; RISK MANAGEMENT; SYMPTOM; THORAX PAIN; TREADMILL EXERCISE; WEIGHT REDUCTION;

EID: 0037078049     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Joint Health Surveys Unit. Health Survey for England. London: Stationery Office; 1998.
2. NSF for Coronary Heart Disease. Chap 4. Available (accessed 9 September 2002).
3. North of England Stable Angina Guidelines development Group. North of England evidence-based guidelines development project: summary version of evidence-based guideline for the primary care management of stable angina. BMJ 1996;312:827-32.
4. Management of stable angina pectoris. Recommendations of the task force of the European Society of Cardiology. Eur Heart J 1997;18:394-413.
5. Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, Lee BK et al, Meta-analysis of trials comparing betablockers, calcium antagonists and nitrates for stable angina. JAMA 1999;281:1927-36.
6. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA et al, for the ASIST Study Group. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: the Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90:762-8.
7. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for reversible airways disease (Cochrane Review). In: Cochrane Library, Issue 1. Oxford: Update Software; 2002.
8. Chan PK, Heo JY, Garibian G, Askenase A, Segal BL, Iskandrian AS. The role of nitrates, beta-blockers and calcium antagonists in stable angina pectoris. Am Heart J 1988;116:838-48.
9. Fox KM, Jespersen CM, Ferrari R, Rehnqvist N. How European cardiologists perceive the role of calcium antagonists in stable angina pectoris. Eur Heart J 1997;18:113-6.
10. Danish study group on verapamil in myocardial infarction. Effects of verapamil on mortality and major events after acute myocardial infarction (DAVIT II). Am J Cardiol 1990; 66:779.
11. Gibson RS, Boden WE, Theroux P, Struass HD, Pratt CM, Gheorghiade M et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomised multi-centre trial. N Eng J Med 1986;315:423.
12. Chrysant SG, Glasser SP, Bittar N, Shahidi FE, Danisa K, Ibrhaim R et al. Efficacy and safety of extended release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol 1993;72:1249-56.
13. The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: The impact of nicorandil in angina (IONA) randomised trial. Lancet 2002;359:1269-75.